Should I buy ABUS stock?
ABUS Stock AnalysisABUS is down -4.21% on 07/17/26.
ABUS is trading in the range of $4.06 - $5.38 in the past 30 days.
Bullish Indicators
Bearish Indicators
Neutral Indicators
| Technical Indicator | Value |
|---|
| 52 Week High | $5.21 | | 52 Week Low | $3.13 | | 200-Day Moving Average | 4.45 | | 50-Day Moving Average | 4.84 | | 20-Day Moving Average | 4.73 | | 10-Day Moving Average | 4.84 | | 5-Day Moving Average | 4.63 | | RSI (14) | 46.96 | | Upper Bollinger Band | 5.20 | | Lower Bollinger Band | 4.25 | | Average True Range (ATR) | 0.25 | | Stochastic Oscillator | 26.63 |
Short term rating on the ABUS stock: NEUTRAL with a score of 3/5.
Compare ABUS with any other stocks with the compare two stocks feature.
| Pivot Point Level |
Floor |
Woodie |
Camarilla |
DeMark |
Fibonacci |
| R4 |
|
|
|
|
|
| R3 |
|
|
|
|
|
| R2 |
|
|
|
|
|
| R1 |
|
|
|
|
|
| PP |
|
|
|
|
|
| S1 |
|
|
|
|
|
| S2 |
|
|
|
|
|
| S3 |
|
|
|
|
|
| S4 |
|
|
|
|
|
Biotechnology Stocks
Health Stocks
Manufacturing Stocks
Pharmaceutical Stocks
Technology Stocks
Mall Stocks
Medicine Stocks
Therapeutic Stocks
Clinic Stocks
Dna Stocks
Lab Stocks
Therapeutics Stocks
Antigen Stocks
Biopharma Stocks
Biopharmaceutical Stocks
Chronic Stocks
Clinical Stocks
Commercialization Stocks
Immune Stocks
Molecule Stocks
Oncology Stocks
Pharma Stocks
Pharmaceuticals Stocks
Pipeline Stocks
Protein Stocks
Research Stocks
Tech Stocks
|